- Home
- Publications
- Publication Search
- Publication Details
Title
Update on gastric cancer treatments and gene therapies
Authors
Keywords
Gastric cancer, Chemotherapy, Metastases, Gene therapy, CRISPR
Journal
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-05
DOI
10.1007/s10555-019-09803-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- CCNE1 amplification is associated with liver metastasis in gastric carcinoma
- (2019) Binnari Kim et al. PATHOLOGY RESEARCH AND PRACTICE
- Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
- (2019) Ruiping Wang et al. GUT
- Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
- (2019) Qianqian Gao et al. Cancer Medicine
- Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial
- (2018) Kakoli Das et al. CANCER LETTERS
- Hallmarks of cancer: The CRISPR generation
- (2018) Colette Moses et al. EUROPEAN JOURNAL OF CANCER
- Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
- (2018) Michael Stahl et al. EUROPEAN JOURNAL OF CANCER
- Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
- (2018) Riccardo Dolcetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer
- (2018) Jun Liu et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Delivery systems of CRISPR/Cas9-based cancer gene therapy
- (2018) Alessio Biagioni et al. Journal of Biological Engineering
- CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells
- (2018) Yi-Qiang Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Type II CRISPR/Cas9 approach in the oncological therapy
- (2017) A. Biagioni et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
- (2017) Julia Joung et al. Nature Protocols
- Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy
- (2017) Xiaolan Deng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Gene-diet interactions in gastric cancer risk: A systematic review
- (2017) Jeongseon Kim et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of Resistance to Chemotherapy in Gastric Cancer
- (2016) J.J.G. Marin et al. Anti-Cancer Agents in Medicinal Chemistry
- TP53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced Gastric Cancer Patients
- (2016) Yong Zha et al. ARCHIVES OF MEDICAL RESEARCH
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
- (2016) Bryan J. Schneider et al. CLINICAL CANCER RESEARCH
- Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
- (2016) Stefano Annunziato et al. GENES & DEVELOPMENT
- Clinical significance of circulating plasma DNA in gastric cancer
- (2016) Wen-Liang Fang et al. INTERNATIONAL JOURNAL OF CANCER
- Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer
- (2016) Yong Zhang et al. MEDICINE
- Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer
- (2016) Feifei Jia et al. Molecular Diagnosis & Therapy
- Molecular mechanisms of peritoneal dissemination in gastric cancer
- (2016) Mitsuro Kanda et al. WORLD JOURNAL OF GASTROENTEROLOGY
- HER2 testing in gastric cancer: An update
- (2016) Lucas Faria Abrahao-Machado et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system
- (2016) Benjamin Garcia-Bloj et al. Oncotarget
- Metastatic spread in patients with gastric cancer
- (2016) Matias Riihimäki et al. Oncotarget
- CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
- (2016) Shu Su et al. OncoImmunology
- Comparison of Gastric Cancer Survival Between Caucasian and Asian Patients Treated in the United States: Results from the Surveillance Epidemiology and End Results (SEER) Database
- (2015) Jiping Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial
- (2015) Shuzhen Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers
- (2015) Alejandra Sandoval-Bórquez et al. DISEASE MARKERS
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriers
- (2015) Rachel S van der Post et al. JOURNAL OF MEDICAL GENETICS
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer
- (2015) Naoki Takahashi et al. Oncotarget
- Erratum: Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma
- (2015) J. Zhang et al. Scientific Reports
- MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
- (2015) Denis L. Fontes Jardim et al. Oncotarget
- Role of p53 in the progression of gastric cancer
- (2015) Rita A. Busuttil et al. Oncotarget
- Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: Potential as a serum biomarker
- (2014) Jong-Baeck Lim et al. CANCER SCIENCE
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
- (2014) Hiroshi Nishimasu et al. CELL
- Zinc finger nucleases: Tailor-made for gene therapy
- (2014) S.-T. Chou et al. DRUGS OF THE FUTURE
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- A Compensatory Role of NF-κB to p53 in Response to 5-FU–Based Chemotherapy for Gastric Cancer Cell Lines
- (2014) Fumitaka Endo et al. PLoS One
- Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
- (2014) Jeeyun Lee et al. PLoS One
- Epigenetics: An emerging player in gastric cancer
- (2014) Changwon Kang WORLD JOURNAL OF GASTROENTEROLOGY
- Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value
- (2014) Felix Berlth WORLD JOURNAL OF GASTROENTEROLOGY
- Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications
- (2014) Danilo do Rosário Pinheiro WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912
- (2013) Y. Yamada et al. ANNALS OF ONCOLOGY
- Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study
- (2013) J.A. Ajani et al. EUROPEAN JOURNAL OF CANCER
- Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
- (2013) Florian Lordick et al. Gastric Cancer
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- Relationship betweenGlutathione S-Transferase P1 (GSTP1), X-Ray Repair Cross Complementing Group 1 (XRCC1) and 5,10-Methylenetetrahydrofolate Reductase (5,10-MTHFR)Gene Polymorphisms and Response to Chemotherapy in Advanced Gastric Cancer
- (2013) Mei Ji et al. ONKOLOGIE
- miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
- (2013) Min Deng et al. PLoS One
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
- (2012) A. M. Dulak et al. CANCER RESEARCH
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains
- (2012) Le Cong et al. Nature Communications
- Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy
- (2011) George Silva et al. CURRENT GENE THERAPY
- Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
- (2011) Hiroyuki Narahara et al. Gastric Cancer
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-126 functions as a tumour suppressor in human gastric cancer
- (2010) Runhua Feng et al. CANCER LETTERS
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
- (2010) Josiane E. Garneau et al. NATURE
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Predictive and prognostic molecular markers for cancer medicine
- (2010) Sunali Mehta et al. Therapeutic Advances in Medical Oncology
- DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's Esophagus
- (2009) Jean S Wang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Race and ethnicity correlate with survival in patients with gastric adenocarcinoma
- (2009) J. Kim et al. ANNALS OF ONCOLOGY
- The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history
- (2009) Daiji Oka et al. CANCER
- Targeted chromosomal deletions in human cells using zinc finger nucleases
- (2009) H. J. Lee et al. GENOME RESEARCH
- Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
- (2008) J B Tuynman et al. BRITISH JOURNAL OF CANCER
- Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
- (2008) V Catalano et al. BRITISH JOURNAL OF CANCER
- Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer
- (2008) C. Bernal et al. CLINICAL CANCER RESEARCH
- EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number
- (2008) M A Kim et al. HISTOPATHOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started